See How Hire2Retire Can Drive Success for Your Organization |17th Oct 2024|

CASE STUDY

Ocular Therapeutix's Journey from Vision to Reality with Hire2Retire Integration

Superior "First Day at Work"
Data Security
Timely Terminations
Role based access control

Industry

Company Size

600

Implemented Solution

Customer

Situation

Ocular Therapeutix, a biopharmaceutical company, is revolutionizing the field of ophthalmology with its innovative drug formulations. By leveraging its proprietary bioresorbable hydrogel-based technology, the company aims to develop sustained-release therapies that simplify the current standard of care and improve patient outcomes. With a robust product pipeline, Ocular Therapeutix is focused on advancing its therapies through clinical trials and commercialization. The company’s first commercial drug, DEXTENZA®, has already gained FDA approval and is making a significant impact in the treatment of ocular inflammation and pain. Today the company is fostering a partnership mindset to maximize the value of its pipeline and unlock new collaborations. With a target market opportunity of $12 billion in the U.S., the company is on a trajectory of rapid growth. 

Struggles and Pains

As the company continued to revolutionize the standard of care with its sustained-release therapies and expanded its product pipeline across multiple therapeutic areas, it encountered several challenges related to in-house HR and identity provisioning processes. With a strong focus on developing groundbreaking products, the company needed robust protection for its intellectual property, technical know-how, and regulatory applications to safeguard exclusivity. Hence, ensuring smooth offboarding processes became crucial to prevent terminated employees from accessing sensitive data and systems. At the same time, growth is indispensable for the company, making efficient onboarding essential to drive collaboration and progress. However, the manual handling of employee lifecycle management tasks proved time-consuming, error-prone, and posed potential data breach risks.  

The lack of integration between the HR system, ADP and AD (Active Directory) resulted in inconsistencies in employee profiles and delayed updates to roles and privileges. This disjointed approach not only hindered collaboration and productivity but also highlighted the pressing need for a comprehensive solution that would automate and streamline HR and identity provisioning processes, ensuring accuracy, efficiency, and compliance. 

Resolution

To address these challenges, Ocular Therapeutix turned to RoboMQ, a trusted provider of data and API integration solutions. RoboMQ offered the perfect solution with its Hire2Retire integration product, which seamlessly integrates HR processes with identity provisioning. By implementing Hire2Retire, Ocular Therapeutix achieved real-time synchronization of employee updates between ADP and the Active Directory. This resulted in significant benefits for the company, including: 

Streamlined employee lifecycle management through the automation of onboarding, role changes, and terminations.

Reduction in manual interventions in employee lifecycle updates resulted in minimized errors and ensured a seamless employee experience.

Real-time allocation of licenses and access to the appropriate teams and departments enabled improved collaboration and productivity.

Automated identity provisioning processes ensured timely updates to roles and privileges, reducing the risk of unauthorized access and ensuring regulatory compliance.

Want to learn more?

Ready to join the wave of companies automating their employee lifecycle management processes with Hire2Retire? Schedule a demo call with us today to see what Hire2Retire can do for your business.

RoboMQ is not affiliated, associated, authorized, endorsed by, or in any way officially connected with any of HR systems that it provides integration with and are mentioned in this case study. All product and company names are the registered trademarks of their original owners. 

MORE CASE STUDIES